J&J/DePuy Charite
This article was originally published in The Gray Sheet
Executive Summary
Artificial spinal disc is on track for a U.S. debut in the first half of 2005 after J&J/DePuy's submission of a PMA application for the first-of-its-kind device Feb. 9. The filing includes data from a 375-patient, 15-center trial with two-year follow-up on 90% of patients. The study aimed to demonstrate equivalency to traditional spinal fusion. However, the firm claims that in many cases patients achieved superior outcomes with the artificial disc. J&J acquired the technology from Link Spine Group in May 2003 (1"The Gray Sheet" May 12, 2003, p. 22)...
You may also be interested in...
J&J/DePuy Charite Artificial Spinal Disc Restores Height By 7.2 MM Average
Johnson & Johnson/DePuy's Charite artificial lumbar disc restores disc space height from an average of 5.7 mm pre-implant to 12.9 mm at 24 months
Biomet’s Interpore Purchase Creates $200 Mil. Spinal Devices Business
Biomet will expand its spinal franchise by nearly one third and gain artificial disc technology via the $280 mil. cash acquisition of Interpore, announced March 8
J&J/DePuy Projects SB Charite Artificial Lumbar Disc PMA Submission In 2004
J&J/DePuy Acromed will establish itself as a player in the nascent artificial spinal disc market through the purchase of Link Spine Group for $325 mil., plus additional milestone payments